Literature DB >> 1730895

Inefficient bacteriolysis of Escherichia coli by serum from human neonates.

H A Lassiter1, J E Tanner, R D Miller.   

Abstract

To assess bacteriolysis in human neonates, Escherichia coli O7w:K1:NM were incubated with sera from eight healthy neonates, serum pooled from the eight neonates, and serum pooled from healthy adults. The adult serum killed E. coli. In contrast, the bacteria were not killed during incubation with sera from the eight neonates, the pooled neonatal serum, or with heat-inactivated adult serum. However, the combination of pooled neonatal serum and heat-inactivated adult serum killed the bacteria. Supplemental IgG-containing antibodies that bound to E. coli did not enhance the bactericidal activity of the neonatal serum. Ten of 12 blood isolates of E. coli from septic neonates but only 8 of 15 isolates from septic adults were serum-sensitive (killed during incubation with adult serum) (P less than .05). Therefore, neonatal serum killed E. coli inefficiently and was deficient in non-IgG heat-stabile component(s) required for bacterial killing. Compared with adults, neonates were more frequently septic with serum-sensitive strains of E. coli.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730895     DOI: 10.1093/infdis/165.2.290

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.

Authors:  O Levy; R B Sisson; J Kenyon; E Eichenwald; A B Macone; D Goldmann
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Influence of some bacterial and host factors on colonization and invasiveness of Escherichia coli K1 in neonatal rats.

Authors:  M Wullenweber; L Beutin; S Zimmermann; C Jonas
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.